Naproxen 220mg [Design Issues]

posted by aanrin – United Arab Emirates, 2016-03-07 09:36 (3764 d 18:32 ago) – Posting: # 16062
Views: 5,001

(edited on 2016-03-07 10:52)

Dear Helmut

In order to conduct a BE study for naproxen 220mg there is no competitor in the market with the same strength. please advise whether we can do the study with the strength 200mg for the comparator. or else what is the regulation in general for this kind of situation when we introduce a new strength.

With regards

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,572 registered users;
256 visitors (0 registered, 256 guests [including 30 identified bots]).
Forum time: 05:08 CEST (Europe/Vienna)

The real struggle is not between the right and the left
but between the party of the thoughtful
and the party of the jerks.    Jimmy Wales

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5